Back to Insider Trading View Full Company Profile

NDAQ

HEALTHY

NASDAQ, INC.

CIK: 0001120193

Strong Sell (70% confidence)

Last activity: Yesterday

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $1.65B
Net Income $352.00M
Total Cash $592.00M
Total Debt $3.47B
Debt/Equity 0.70

Insider Roster (5 total, 5 active)

Insider Buys Sells Net Value Holdings
FRIEDMAN ADENA T
Chair and CEO
0 2 -$57.99M
1,924,903 shares
$186.54M
INVESTOR AB
OTHER
1 0 $15.84M
58,382,426 shares
$4.62B
Zecca John
EVP, Global CLO
0 1 -$450K
125,674 shares
$12.57M
Smith Bryan Everard
EVP, CPO
0 1 -$420K
57,670 shares
$5.22M
SKULE JEREMY
EVP, CSO
0 1 -$191K
82,869 shares
$7.51M

Recent Transactions

BUY INVESTOR AB (OTHER)

200,000 shares @ $79.18

$15.84M

Feb 13, 2026

Conviction: | View SEC Filing →
SELL FRIEDMAN ADENA T (Chair and CEO)

300,000 shares @ $96.91

$29.07M

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Zecca John (EVP, Global CLO)

4,500 shares @ $100.01

$450K

Jan 6, 2026

Conviction: | View SEC Filing →
SELL FRIEDMAN ADENA T (Chair and CEO)

300,000 shares @ $96.39

$28.92M

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Smith Bryan Everard (EVP, CPO)

4,633 shares @ $90.57

$420K

Dec 1, 2025

Conviction: | View SEC Filing →
SELL SKULE JEREMY (EVP, CSO)

2,105 shares @ $90.57

$191K

Dec 1, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.